艾美捷科技代理STEMCELL Technologies品牌。

STEMCELL Technologies为世界各地从事干细胞、免疫学、癌症、再生医学和细胞治疗研究的科学家提供高质量的细胞培养基、细胞分离技术、仪器和配套产品。

STEMCELL Technologies特色产品包括：

（1）EasySep™ 总核酸提取试剂盒：磁性总核酸（DNA 和 RNA）提取试剂盒

（2）CellAdhere™ Laminin-521：与 TeSR™ 维持培养基结合用于维持人 ES 和 iPS 细胞的基质

（3）EasySep™ 人骨髓 CD138 阳性选择试剂盒 (IVD)：从骨髓中免疫磁性阳性选择人 CD138+ 细胞用于体外诊断 (IVD) 应用的样品

（4）GyneCult™ 输卵管类器官培养基：无血清和性类固醇模块化试剂盒，用于人类输卵管类器官的扩增和分化

Affinity Biosciences成立于2006年，是一家开创性的生命科学和高科技公司，其生化产品和服务主要应用于生物技术，医学研究和药物开发。Affinity Biosciences致力于通过创新推动客户成功，在英国和美国建立了研发部门，旨在为全球提供卓越的服务。我们的客户包括科学家和技术人员在生命科学公司，大学和政府机构，医院和行业。为了强化对客户的承诺，提升服务水平，我们在中华人民共和国开设了包装和质量控制设施。我们的目标是开发重点是细胞信号转导研究的高质量抗体，包括Akt，AMPK，NF-KappaB，TGF-β等，以及抑制剂和相关试剂。

Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.

Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.